(Q43653247)

25 November 2017

title

Surgical management of macular holes: a report by the American Academy of Ophthalmology (English)

1 reference

25 November 2017

Benson WE

1

1 reference

25 November 2017

Cruickshanks KC

2

1 reference

25 November 2017

Fong DS

3

1 reference

25 November 2017

Williams GA

4

1 reference

25 November 2017

Bloome MA

5

1 reference

25 November 2017

Frambach DA

6

1 reference

25 November 2017

Kreiger AE

7

1 reference

25 November 2017

Murphy RP

8

1 reference

25 November 2017

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

108

1 reference

25 November 2017

issue

7

1 reference

25 November 2017

page(s)

1328-1335

1 reference

Idiopathic senile macular hole. Its early stages and pathogenesis

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Reappraisal of biomicroscopic classification of stages of development of a macular hole

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Optical coherence tomography of macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Macular hole formation: new data provided by optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Foveal pseudocyst as the first step in macular hole formation: a prospective study by optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Vitreous surgery for idiopathic macular holes. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial. Vitrectomy for Prevention of Macular Hole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Bilateral visual function after macular hole surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Visual function and patient satisfaction after macular hole surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Macular hole surgery with internal-limiting membrane peeling and intravitreous air

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Surgical management of macular holes: results using gas tamponade alone, or in combination with autologous platelet concentrate, or transforming growth factor beta 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Autologous platelet concentrate in the surgical management of macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Distribution of iatrogenic retinal breaks in macular hole surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Posterior segment complications after vitrectomy for macular hole

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Long-term visual outcomes in patients with successful macular hole surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Macular hole surgery without face-down positioning. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Macular hole surgery using thrombin-activated fibrinogen and selective removal of the internal limiting membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Late re-opening of macular holes after initially successful treatment with vitreous surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Long-term incidence of reopening of macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Reopening of macular holes after initially successful repair

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Internal limiting membrane removal in the management of full-thickness macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Use of autologous platelet concentrate in macular hole surgery: report of 77 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Effect of perifoveal tissue dissection in the management of acute idiopathic full-thickness macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Macular hole surgery with and without internal limiting membrane peeling

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

The macular hole: report of an Australian surgical series and meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Incidence of idiopathic full-thickness macular holes in fellow eyes. A 5-year prospective natural history study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Bilaterality of idiopathic macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Vitrectomy for Macular Hole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Macular hole surgery. Comparison of longstanding versus recent macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Results of surgical treatment of recent-onset full-thickness idiopathic macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Success with macular hole surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Human autologous serum for the treatment of full-thickness macular holes. A preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Surgical treatment of full-thickness macular holes using autologous serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Treatment of full-thickness macular holes with autologous serum

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Surgical closure of macular hole using an absorbable macular plug.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Thrombin in the management of full thickness macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Diamond-dusted silicone cannula for epiretinal membrane separation during vitreous surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Intraocular tamponade duration and success of macular hole surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

Silicone oil tamponade to seal macular holes without position restrictions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900731-X

7 January 2021

10.1016/S0161-6420(01)00731-X

Identifiers

DOI

1 reference

25 November 2017

1 reference